New scan method could catch 20% more hidden cancers
NCT ID NCT06527027
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares three methods for reading CT and MRI scans of lymph nodes to see which best detects cancer. The new method, LN-RADS, may find small metastases that current guidelines miss. Researchers will enroll 1,000 people with known or suspected cancer who need a lymph node biopsy. The goal is to see if LN-RADS is more accurate than the standard RECIST 1.1 and the newer Node-RADS systems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If LN-RADS works better, doctors could detect more lymph node metastases, leading to more accurate cancer staging and better treatment decisions.
What could go wrong
This is a diagnostic comparison study, not a treatment trial. Even if LN-RADS is more accurate, it may not improve patient outcomes or be adopted widely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPH NODE METASTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Copernicus Memorial Hospital
RECRUITINGLodz, 93-513, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Doradztwo i Zarządzanie w Opiece Zdrowotnej A.K. Sp.z o.o
ACTIVE_NOT_RECRUITINGWarsaw, Poland
-
Independent Public Healthcare Centre (SPZOZ) , University Clinical Hospital No. 2 of the Medical University of Łódź
ACTIVE_NOT_RECRUITINGLodz, Poland
-
Maria Skłodowska-Curie National Research Institute of Oncology - National Research Institute
ACTIVE_NOT_RECRUITINGKrakow, Poland
-
Maria Skłodowska-Curie National Research Institute of Oncology - National Research Institute
ACTIVE_NOT_RECRUITINGWarsaw, Poland
-
Professor Orłowski Hospital in Warsaw , Independent Public Healthcare Centre
ACTIVE_NOT_RECRUITINGWarsaw, Poland